4
Changes in Ownership
Cabaletta Bio, Inc. Filed Acc 0000950170-23-049005
See Remarks sold 11,000 shares at an average $17.57 ($193,220)
- See Remarks acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Binder Gwendolyn See Remarks | 2023-09-19 | Option exercise 10b5-1 | +11,000 | $1.01 | $11,110 | 31,000 | D |
| Binder Gwendolyn See Remarks | 2023-09-19 | Sale 10b5-1 | −10,300 | $17.50 | $180,270 | 20,700 | D |
| Binder Gwendolyn See Remarks | 2023-09-19 | Sale 10b5-1 | −700 | $18.50 | $12,950 | 20,000 | D |
| Derivatives | |||||||
| Binder Gwendolyn See Remarks | 2023-09-19 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,000 | 144,756 | D | ||
| Open-market sales · 11,000 sh · avg $17.57 · $193,220 | |||||||
Loading xslF345X05/ownership.xml…